117 related articles for article (PubMed ID: 7173315)
21. Comparison of the behavioral and neurochemical effects of 5,7-DHT, MDMA and D,L-fenfluramine.
Lorens SA; Hata N; Cabrera T; Hamilton ME
NIDA Res Monogr; 1989; 95():347. PubMed ID: 2577039
[No Abstract] [Full Text] [Related]
22. Sexual behavior in male rats after intracerebral injection of 5,7-dihydroxytryptamine.
Larsson K; Fuxe K; Everitt BJ; Holmgren M; Södersten P
Brain Res; 1978 Feb; 141(2):293-303. PubMed ID: 626904
[No Abstract] [Full Text] [Related]
23. The effect of intracerebral injections of 5,7-dihydroxytryptamine and 6-hydroxydopamine on the serotonin-immunoreactive cell bodies and fibers in the adult rat hypothalamus.
Frankfurt M; Azmitia E
Brain Res; 1983 Feb; 261(1):91-9. PubMed ID: 6404500
[No Abstract] [Full Text] [Related]
24. Long-lasting depletion of spinal cord 5-hydroxytryptamine or catecholamines after intraspinal injection of 5,7-dihydroxytryptamine or 6-hydroxydopamine to newborn rats.
Carruba MO; Keller HH; Da Prada M
Neurosci Lett; 1983 Feb; 35(2):173-8. PubMed ID: 6190112
[No Abstract] [Full Text] [Related]
25. Effects of 5,7-dihydroxytryptamine and p-chlorophenylalanine on temperature regulation in rats.
Lin MT; Pang IH; Chern YF; Chern SI
J Pharm Pharmacol; 1978 Nov; 30(11):723-5. PubMed ID: 31440
[No Abstract] [Full Text] [Related]
26. [3H]imipramine binding in subcellular fractions of rat cerebral cortex after chemical lesion of serotonergic neurons.
Sette M; Ruberg M; Raisman R; Scatton B; Zivkovic B; Agid Y; Langer SZ
Eur J Pharmacol; 1983 Nov; 95(1-2):41-51. PubMed ID: 6199218
[TBL] [Abstract][Full Text] [Related]
27. Autoradiographic characterization of [3H]imipramine and [3H]citalopram binding in rat and human brain: species differences and relationships to serotonin innervation patterns.
Duncan GE; Little KY; Kirkman JA; Kaldas RS; Stumpf WE; Breese GR
Brain Res; 1992 Sep; 591(2):181-97. PubMed ID: 1332802
[TBL] [Abstract][Full Text] [Related]
28. Temporal effects of intrahypothalamic 5,7-dihydroxytryptamine: relationship between serotonin levels and [3H]serotonin binding.
Frankfurt M; Allen DL; Luine VN; Beaudet A
Brain Res; 1987 Sep; 419(1-2):216-22. PubMed ID: 2445421
[TBL] [Abstract][Full Text] [Related]
29. Effects of neonatal treatment with 5,7-dihydroxytryptamine or 6-hydroxydopamine on the ontogenetic development of the audiogenic immobility reaction in the rat.
Hard E; Ahlenius S; Engel J
Psychopharmacology (Berl); 1983; 80(3):269-74. PubMed ID: 6412273
[TBL] [Abstract][Full Text] [Related]
30. Alterations in serotonin binding sites after 5,7-dihydroxytryptamine treatment in the rat spinal cord.
Brown LM; Smith DL; Williams GM; Smith DJ
Neurosci Lett; 1989 Jul; 102(1):103-7. PubMed ID: 2779841
[TBL] [Abstract][Full Text] [Related]
31. [Selective lesions of serotonergic raphe neurons produced by 5,7-dihydroxytryptamine: effects on interspecific aggressive behavior in the rat].
Vergnes M; Penot C; Kempf E; Mack G
Brain Res; 1977 Sep; 133(1):167-71. PubMed ID: 561640
[No Abstract] [Full Text] [Related]
32. Characterization of typical and atypical antidepressant recognition sites in rat brain.
Brunello N; Chuang DM; Costa E
Adv Biochem Psychopharmacol; 1982; 31():179-84. PubMed ID: 6211062
[No Abstract] [Full Text] [Related]
33. Intracortical 5,7-dihydroxytryptamine depletes brain serotonin concentrations without affecting spontaneous activity.
Black RS; Robinson RG
Pharmacol Biochem Behav; 1985 Feb; 22(2):327-31. PubMed ID: 3983223
[TBL] [Abstract][Full Text] [Related]
34. Labeling in vivo of serotonin uptake sites in rat brain after administration of [3H]cyanoimipramine.
Wolfe J; Kreider MS; Goodman C; Brunswick DJ
J Pharmacol Exp Ther; 1987 Apr; 241(1):196-203. PubMed ID: 3572782
[TBL] [Abstract][Full Text] [Related]
35. Effects of microinjections of 5,7-dihydroxytryptamine in the suprachiasmatic nuclei of the rat on serotonin reuptake and the circadian variation of corticosterone levels.
Williams JH; Miall-Allen VM; Klinowski M; Azmitia EC
Neuroendocrinology; 1983 Jun; 36(6):431-5. PubMed ID: 6877522
[TBL] [Abstract][Full Text] [Related]
36. 3H-5-hydroxytryptamine accumulation by rat brain synaptic vesicles in a membrane-impermeant medium, and selective reduction by 5,7-dihydroxytryptamine.
Ruth JA; Cuizon JV; Park SH; Ullman EA; Wilson WR
Life Sci; 1986 Mar; 38(13):1193-201. PubMed ID: 3959750
[TBL] [Abstract][Full Text] [Related]
37. Interaction of 5,6- and 5,7-dihydroxytryptamine with tissue monoamine oxidase.
Klemm HP; Baumgarten HG
Ann N Y Acad Sci; 1978 Jun; 305():36-56. PubMed ID: 280252
[No Abstract] [Full Text] [Related]
38. Increased tilt-cage activity after serotonin depletion by 5,7-dihydroxytryptamine.
Mackenzie RG; Hoebel BG; Norelli HC; Trulson ME
Neuropharmacology; 1978 Nov; 17(11):957-63. PubMed ID: 152872
[No Abstract] [Full Text] [Related]
39. Receptor mechanisms in increased sensitivity to serotonin agonists after dihydroxytryptamine shown by electronic monitoring of muscle twitches in the rat.
Stewart RM; Campbell A; Sperk G; Baldessarini RJ
Psychopharmacology (Berl); 1979 Feb; 60(3):281-9. PubMed ID: 108706
[No Abstract] [Full Text] [Related]
40. Effect of 5,7-dihydroxytryptamine on the concentration of individual proteins in different areas of the rat brain.
Heydorn WE; Creed GJ; Nguyen KQ; Jacobowitz DM
Brain Res; 1986 Mar; 368(1):193-6. PubMed ID: 3006866
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
